Afelimomab | Interleukin Related interleukin-related.com

Product Name :
Afelimomab

Search keywords :
Afelimomab

drugId :
null

Target Vo:
Tumor necrosis factor

Target Vo Short Name :
TNF

Moa_Name:
Tumor necrosis factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Abbott Laboratories

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Shock, Septic

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Inclacumab Protocol
IL-1 beta Rabbit pAb manufacturer
WDR5 Antibody: WDR5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to WDR5. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts